Sigma receptor type 1 gene variation in a group of polish patients with Alzheimer's disease and mild cognitive impairment

Dementia and Geriatric Cognitive Disorders

Volumn 23, Issue 6, 2007, Pages 432-438

  Maruszak, Aleksandra ^a   Safranow, Krzysztof ^b   Gacia, Magdalena ^a   Gabryelewicz, Tomasz ^a   Słowik, Agnieszka ^c   Styczyńska, Maria ^a   Pepłońska, Beata ^a   Golan, Maciej P ^a   Zekanowski, Cezary ^a   Barcikowska, Maria ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Alzheimer's disease; Mild cognitive impairment; Sigma receptor type 1 gene

Indexed keywords

SIGMA 1 OPIATE RECEPTOR;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; FEMALE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; MALE; ODDS RATIO; POLAND; RECEPTORS, SIGMA; VARIATION (GENETICS);

EID: 34250207381     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101990     Document Type: Article

References (28)

1. Yamamoto H, Miura R, Yamamoto T, Shinohara K, Watanabe M, Okuyama S, Nakazato A, Nukada T: Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding. FEBS Lett 1999;445:19-22.
2. Aydar E, Palmer CP, Djamgoz MBA: Sigma receptors and cancer. Possible involvement of ion channels. Cancer Res 2004;64:5029-5035.
3. Prasad PD, Li HW, Fei YJ, Ganapathy ME, Fujita T, Plumley LH, Yang-Feng TL, Leibach FH, Ganapathy V: Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 sigma receptor gene. J Neurochem 1998;70:443-451.
4. Duncan G, Wang L: Focus on molecules: the sigma-1 receptor. Exp Eye Res 2005;81:121-122.
5. Takebayashi M, Hayashi T, Su T-P: A perspective on the new mechanism of antidepressants: neuritogenesis through sigma-1 receptors. Pharmacopsychiatry 2004;37:208-213.
6. Bermack JE, Debonnel G: The role of sigma receptors in depression. J Pharmacol Sci 2005;97:317-336.
7. Su TP, Hayashi T: Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr Med Chem 2003;10:2073-2080.
8. 2+ concentration. J Pharmacol Exp Ther 2000;293:788-798.
9. 1) receptor: pharmacological evidence and therapeutic opportunities. Jpn J Pharmacol 1999;81:1125-1155.
10. 1) receptor in the anti-amnesic effect of neuroactive steroids, as demonstrated using an in vivo antisense strategy in the mouse. Br J Pharmacol 2001;134:1731-1741.
11. 1 receptors: implications for antidepressants. J Pharmacol Exp Ther 2002;303:1227-1237.
12. 25-35 -amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience 1998;83:413-428.
13. 1 receptor in the adult rat central nervous system. Neuroscience 2000;97;155-170.
14. Uchida N, Ujike H, Tanaka Y, Sakai A, Yamamoto M, Fujisawa Y, Kanzaki A, Kuroda S: A variant of the sigma receptor type-1 gene is a protective factor for Alzheimer disease. Am J Geriatr Psychiatry 2005;13:1062-1066.
15. Ishiguro H, Ohtsuki T, Toru M, Itokawa M, Aoki J, Shibuya H, Kurumaji A, Okubo Y, Iwawaki A, Ota K, Shimizu H, Hamaguchi H, Arinami T: Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia. Neurosci Lett 1998;257:45-48.
16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
17. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Kokmen E, Tangelos EG: Aging, memory, and mild cognitive impairment. Int Psychogeriatr 1997;9(suppl 1):65-69.
18. Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
19. Styczynska M, Religa D, Pfeffer A, Luczywek E, Wasiak B, Styczynski G, Peplonska B, Gabryelewicz T, Golebiowski M, Kobrys M, Barcikowska M: Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease. Neurosci Lett 2003;344:99-102.
20. Chapman J, Estupinan J, Asherow A: A simple and efficient method for apolipoprotein E genotype determination. Neurology 1996;46:1484-1485.
21. Sasieni PD: From genotypes to genes: doubling the sample size. Biometrics 1997;53:1253-1261.
22. Terwilliger J, Ott J: Handbook for Human Genetic Linkage. Baltimore, Johns Hopkins University Press, 1994.
23. Earley B, Burke M, Leonard BE, Gouret CJ, Junien JL: Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor. Brain Res 1991;546:282-286.
24. Matsuno K, Senda T, Matsunaga K, Mita S: Ameliorating effects of sigma receptor ligands on the impairment of passive avoidance tasks in mice: involvement in the central acetylcholinergic system. Eur J Pharmacol 1994;261:43-51.
25. Matsuno K, Senda T, Kobayashi T, Okamoto K, Nakata K, Mita S: SA4503: a novel cognitive enhancer with sigma1 receptor agonistic properties. Behav Brain Res 1997;83:221-224.
26. Senda T, Matsuno K, Kobayashi T, Nakazawa M, Nakata K, Mita S: Ameliorative effect of SA4503, a novel cognitive enhancer on the basal forebrain lesion-induced impairment of the spatial learning performance in rats. Pharmacol Biochem Behav 1998;59:129-134.
27. Maurice T: Improving Alzheimer's disease-related cognitive deficits with sigma1 receptor agonists. Drug News Perspect 2002;15:617-625.
28. Guitart X, Codony X, Monroy X: Sigma receptors: biology and therapeutic potential. Psychopharmacology 2004;174:301-319.